Skip to content

Clinical trials

Not yet recruiting Phase 1/2 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Status: Not yet recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20241
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCAGY/ GINECO GROUP1
Advenchen Pharmaceuticals, LLC.1
BioMimetix JV, LLC1
LG Chem1
NovaOnco Therapeutics Co., Ltd.1
Phrontline Biopharma1
Qilu Pharmaceutical Co., Ltd.1
Seoul National University Hospital1
Shanghai Gynecologic Oncology Group1
Tongji Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms10
Endometrial Neoplasms5
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Esophageal Neoplasms1
Fallopian Tube Neoplasms1
Glioblastoma1
Head and Neck Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.